FGF21 and Alzheimer disease: Post-treatment analysis revealed that FGF-21 reduced BACE1 levels in the brain and reversed the inflammatory imbalance between IL-6, TNF-α and IL-10, thereby significantly improving the cognitive function of AD models [99].